Olprinone improves diaphragmatic contractility and fatigability during abdominal sepsis in a rat model

Acta Anaesthesiologica Scandinavica

Volumn 48, Issue 5, 2004, Pages 637-641

  Miyakawa, Hiroshi ^a   Oishi, K ^a   Hagiwara, S ^a   Kira, S ^a   Kitano, T ^a   Iwasaka, H ^a   Noguchi, T ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Abdominal sepsis; Diaphragmatic fatigability; Myeloperoxidase; Olprinone; Phosphodiesterase inhibitor

Indexed keywords

LOPRINONE; MYELOPEROXIDASE; PANCURONIUM BROMIDE; PHOSPHODIESTERASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CECUM; CONTROLLED STUDY; DIAPHRAGM MUSCLE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; EXPERIMENTAL MODEL; HEMIDIAPHRAGM; LEUKOCYTE ACTIVATION; MALE; MEASUREMENT; MUSCLE CONTRACTILITY; MUSCLE FATIGUE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY FAILURE; SEPSIS; TIME SERIES ANALYSIS;

ABDOMEN; ANALYSIS OF VARIANCE; ANIMALS; CARDIOTONIC AGENTS; CECUM; DIAPHRAGM; DISEASE MODELS, ANIMAL; IMIDAZOLES; INJECTIONS, INTRAPERITONEAL; MALE; MUSCLE CONTRACTION; MUSCLE FATIGUE; NEUTROPHIL ACTIVATION; PEROXIDASE; PYRIDONES; RATS; RATS, WISTAR; SEPSIS;

EID: 2442450341     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-5172.2004.00385.x     Document Type: Article

References (17)

1. Anzueto A, Supinski GS, Levine SM, Jenkinson SG. Mechanisms of disease. Are oxygen-derived free radicals involved in diaphragmatic dysfunctions? Am J Respir Crit Care Med 1994; 149: 1048-52.
2. Hussain SNA. Respiratory muscle dysfunction in sepsis. Mol Cell Biochem 1998; 179: 125-35.
3. Fujimura N, Sumita S, Aimono M et al. Effect of free radical scavengers on diaphragmatic contractility in septic peritonitis. Am J Respir Crit Care Med 2000; 164: 2159-65.
4. Fujimura N, Sumita S, Narimatsu E. Alternation in diaphragmatic contractility during septic peritonitis in rats: Effect of polyethylene glycol-absorbed superoxide dismutase. Crit Care Med 2000; 28: 2406-14.
5. Bernardin G, Strosberg AD, Bernard A, Mattei M, Marullo S. β-adrenergic receptor-dependent and - independent stimulation of adenylate cyclase is impaired during severe sepsis in humans. Intensive Care Med 1998; 24: 1315-22.
6. Fujimura N, Sumita S, Narimatsu E, Nakayama Y, Shichinohe Y, Namiki A. Effect of isoproterenol on diaphragmatic contractility in septic peritonitis. Am J Respir Crit Care Med 2000; 161: 440-6.
7. Van Der Heijden HFM, Zhan WZ, Prakash YS, Dekhuijzen PNR, Sieck GC. Salbutamol enhances isotonic contractile properties of rat diaphragm muscle. J Appl Physiol 1998; 85: 525-9.
8. Fujii Y, Takahashi S, Toyooka H. The effects of milrinone and its mechanism in the fatigued diaphragm in dogs. Anesth Analg 1998; 87: 1077-82.
9. Supinski G, Stofan D, Challahan LA, Nethery D, DiMaco A. Effects of protein kinase A inhibition on rat diaphragm force generation. Respir Physiol 2000; 120: 115-23.
10. Chanani NK, Cowan DB, Takeuchi K et al. Differential effects of amrinone and milrinone upon myocardial inflammatory signaling. Circulation 2002; 24: 284-289.
11. Wichterman KA, Baue AE, Chaudary IH. Sepsis and septic shock. A review of laboratory models and a proposal. J Surg Res 1980; 29: 189-201.
12. Fink MP, Heard SO. Laboratory models of sepsis and septic shock. J Surg Res 1990; 49: 186-96.
13. Taoka Y, Okajima K, Uchiba M et al. Activated protein C reduces the severity of compression-induced spinal cord injury in rats by inhibiting activation of leukocytes. J Neurosci 1998; 18: 1393-8.
14. Mizutani A, Okajima K, Uchiba M, Noguchi T. Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood 2000; 95: 3781-7.
15. Boczkowski J, Dureuil B, Branger D, Mureciano D, Pariente R, Aubier M. Effects of sepsis on diaphragmatic function on rats. Am Rev Respir Dis 1988; 138: 260-5.
16. Cohen CA, Zaelbaum G, Gross D, Roussos C, Macklem PT. Clinical manifestation of inspiratory muscle fatigue. Am J Med 1982; 73: 308-16.
17. Murray F, MacLean MR, Pyne NJ. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension. Br J Pharmacol 2002; 137: 1187-94.